(National Research, Development, and Innovation Office grant K 119381)
Támogató: MTA Lendület
(National Research, Development, and Innovation Office grants K 128247)
(National Research, Development, and Innovation Office grants FK 128252)
Szakterületek:
Állatorvosi tudományok
Klinikai orvostan
Porcine reproductive and respiratory syndrome (PRRS) is a globally spread, highly
infectious viral disease. Live, attenuated vaccines against PRRS virus (PRRSV) decrease
virus excretion and evoke protective immunity reducing the economic damage caused
by the disease. In a longitudinal molecular epidemiological study accompanying ongoing
national eradication programme we evaluated the suitability of PRRSV ORF5 and ORF7
sequences to identify possible field strains of vaccine-origin. In total, 2342 ORF5
sequences and 478 ORF7 sequences were analysed. Vaccine strains were identified by
sequence identity values and phylogenetic network analysis. Strains that shared greater
than 98% nucleotide identity within ORF5 and/or ORF7 were considered to have originated
from vaccine. A total of 882 (37.6%) ORF5 and 88 (18.4%) ORF7 sequences met these
criteria. In detail, 618, 179 and 35 ORF5 and 51, 29 and 8 ORF7 sequences were related
to Porcilis PRRS vaccine, Unistrain PRRS vaccine, and ReproCyc PRRS EU vaccine, respectively.
Data showed that the Porcilis vaccine was genetically more stable. Whereas, the variability
of the Unistrain and the ReproCyc strains was significantly higher. Given that ORF7
shares, in some instances, complete identity between a particular vaccine strain and
some historic variants of field PRRSV strains, care must be taken when evaluating
vaccine relatedness of a field isolate based on the ORF7. On the contrary, ORF5 sequences
were more suitable to predict the vaccine origin making a distinction more robustly
between field and vaccine strains. We conclude that ORF5 based molecular epidemiological
studies support more efficiently the ongoing PRRS eradication programmes. The conclusions
presented in this large-scale PRRS molecular epidemiological study provides a framework
for future eradication programmes planned in other countries.